Skip to main content
. 2016 Apr 22;6(2):16. doi: 10.3390/diagnostics6020016

Table 1.

Comparing subgroups of individuals with chronic fatigue syndrome (CFS) defined by age and illness duration on mean functioning and symptomatology (N = 652).

Variables Younger (<55), Illness Duration <10 Years Younger (<55), Illness Duration >10 Years Older (>55), Illness Duration <10 Years Older (>55), Illness Duration >10 Years Sig.
(n = 334) (n = 107) (n = 76) (n = 135)
M (SD) M (SD) M (SD) M (SD)
SF-36 Subscales
Vitality 17.9 (15.5) a 13.2 (12.3) a 14.6 (15.4) 18.8 (16.4) *
Physical Functioning 38.5 (23.1) 30.6 (22.8) 31.1 (22.9) 37.3 (21.4) *
Role Physical 5.7 (17.0) 5.8 (17.5) 6.4 (11.8) 4.6 (16.2) -
Bodily Pain 40.8 (25.5) 40.0 (25.8) 38.2 (22.8) 44.2 (21.0) -
General Health 27.2 (16.6) 24.1 (16.3) 27.2 (16.3) 30.4 (17.4) -
Social Functioning 26.9 (23.1) 22.7 (23.2) 24.7 (24.8) 31.7 (24.8) -
Mental Health 67.5 (18.7) a 67.7 (17.5) b 64.6 (19.7) c 73.8 (16.7) a,b,c **
Role Emotional 72.9 (40.4) 73.8 (41.8) 64.4 (43.3) 74.4 (37.7) -
Domain Composites
Fatigue/PEM 50.7 (22.8) 53.7 (23.4) 52.2 (24.4) 45.3 (24.9) -
Sleep Dysfunction 34.8 (19.4) 36.8 (18.7) 34.8 (17.2) 30.2 (18.1) -
Pain 28.7 (18.4) 30.8 (20.3) 29.8 (16.4) 23.7 (14.5) -
Neurocognitive 70.3 (40.2) 63.1 (32.3) 77.0 (37.3) 62.7 (36.7) -
Autonomic 23.9 (17.7) 27.9 (20.8) a 23.9 (15.6) 18.3 (15.4) a *
Neuroendocrine 29.5 (22.8) a 31.2 (20.4) 27.5 (15.0) 21.7 (20.8) a *
Immune 23.4 (16.3) 25.6 (16.3) a 21.4 (13.4) 18.1 (14.1) a *

* p < 0.05, ** p < 0.01. Similar letters (a, b and c) across rows indicate significant differences in post-hoc analyses.